NASDAQ:GALT | Free Cash Flow | GALECTIN THERAPEUTICS INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.87M
2025-12-31-$6.04M
2025-03-31-$7.69M
2024-12-31-$12.79M
2024-03-31-$12.11M
2023-12-31-$4.7M
2023-03-31-$10.79M
2022-12-31-$7.24M
2022-03-31-$8.04M
2021-12-31-$6.95M
2021-03-31-$6.38M
2020-12-31-$5.41M
2020-03-31-$4.37M
2019-12-31-$3.76M
2019-03-31-$3.28M
2018-12-31-$2.01M
2018-03-31-$3.52M
2017-12-31-$3.9M
2017-03-31-$3.86M
2016-12-31-$4.87M
2016-03-31-$3.49M
2015-12-31-$4.6M
2015-03-31-$4.31M
2014-12-31-$3.11M
2014-03-31-$3.62M
2013-12-31-$1.65M
2013-03-31-$2.42M
2012-12-31-$1.75M$3,000.00-$1.75M
2012-03-31-$1.49M
2011-12-31-$1.54M$0.00-$1.54M
2011-03-31-$1.37M
2010-12-31-$583,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$23.88M
2024-12-31-$41.77M
2023-12-31-$32.97M
2022-12-31-$31.06M
2021-12-31-$24.31M
2020-12-31-$20.6M
2019-12-31-$10.85M
2018-12-31-$10.18M
2017-12-31-$15.89M
2016-12-31-$16.41M
2015-12-31-$16.98M$0.00-$16.98M
2014-12-31-$12.43M$0.00-$12.43M
2013-12-31-$7.48M$0.00-$7.48M
2012-12-31-$7.5M$5,000.00-$7.51M
2011-12-31-$5.68M$5,000.00-$5.68M
2010-12-31-$3.1M